Andrew Briskin - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Andrew Briskin's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Andrew Briskin
Verified
Editor, diaTribe
Pennsylvania
Beats
Health , Technology , Health, Healthcare, Public , Health , Social , Care, MHealth , Medical Devices , Health Technology , Service Improvement, Nursing, Service , Improvement , Medical , Technology, Health Tech, Medicine, History of Medicine, Disease , Medical , Devices
Trauma, War, Violent Crimes
Content
By Andrew Briskin Verified, Susannah Chen Verified| diaTribe Verified Brenzavvy, a type 2 diabetes drug recently approved by the FDA, has just become commercially available at lower cost with no insurance required. Pharmaceutical company TheracosBio has announced that Brenzavvy (bexagliflozin) is now available in the US. The medication is obtainable with a prescription through Cost Plus Drugs, a company that negotiates directly with manufacturers to offer medications at a lower price. Cost Plus is offering a 30-day supply for $47.85 plus shipping and handling.
By Andrew Briskin Verified| diaTribe Verified An analysis shows Tandem’s Control-IQ automated insulin delivery system boosts time in range by three hours per day, largely due to the system's auto-correction feature. The study published in Diabetes Technology & Therapeutics showed that time in range (TIR) improvements from the hybrid-closed loop technology were seen among all participants, regardless of age, race, income, starting A1C, or prior use of diabetes technology.
By Andrew Briskin Verified, Susannah Chen Verified| diaTribe Verified Brenzavvy, a type 2 diabetes drug recently approved by the FDA, has just become commercially available at lower cost with no insurance required. Pharmaceutical company TheracosBio has announced that Brenzavvy (bexagliflozin) is now available in the US. The medication is obtainable with a prescription through Cost Plus Drugs, a company that negotiates directly with manufacturers to offer medications at a lower price. Cost Plus is offering a 30-day supply for $47.85 plus shipping and handling.
Company Info
diaTribe
The diaTribe Foundation is a non-profit organization based in San Francisco, California, focused on improving the lives of individuals affected by diabetes and prediabetes. Founded by Kelly Close, the foundation aims to provide education, advocacy, and convening opportunities to help people manage their conditions effectively. The foundation offers free online educational resources through diaTribe Learn, which provides management tips and insights into the latest research and treatments. It also advocates for policy changes to enhance access to therapies and technologies, amplifying the voices of those with diabetes. Additionally, the diaTribe Foundation convenes stakeholders to address diabetes-related issues, including initiatives like The Time in Range Coalition and the dStigmatize program to combat stigma associated with diabetes. Led by CEO Jim Carroll, the diaTribe Foundation reaches over 6 million people annually, including individuals with diabetes, healthcare professionals, and policymakers. The organization emphasizes transparency and accountability in its operations.
'+1 415-241-9500
Founded: 2012